Stocky
EXEL
Exelixis, Inc.
NASDAQ · Healthcare · US
56.70
▲ +1.25%

What's happening at Exelixis, Inc.

Exelixis, Inc.'s latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 6 Aug 2026
Big update 5 Aug 2026

Reports Q2 2026 financial results and corporate update

Shows how the company performed financially in the second quarter, helping you understand if the business is growing.

SEC 10-Q · filed 2026-08-05 View filing ↗
Earnings 5 Aug 2026

Reports Q2 2026 financial results and corporate update

Shows how the company performed financially in the second quarter, helping you understand if the business is growing.

SEC 8-K · filed 2026-08-05 View filing ↗
Governance 29 May 2026

Stockholders elect 11 directors and approve equity plan amendment

Shareholders chose leaders to run the company and approved how employees get stock rewards.

SEC 8-K · filed 2026-05-29 View filing ↗
Earnings 5 May 2026

Reports Q1 2026 financial results and corporate update

Shows how the company performed financially in the first quarter, helping you understand if the business is growing.

SEC 10-Q · filed 2026-05-05 View filing ↗
Money 5 May 2026

Authorizes $750 million stock buyback through December 2027

The company will buy back its own stock, which can increase value for remaining shareholders.

SEC 8-K · filed 2026-05-05 View filing ↗
Earnings 10 Feb 2026

Reports full year 2025 financial results and executive compensation

Shows the company's annual performance and how much leaders earned, giving you the full-year picture.

SEC 10-K · filed 2026-02-10 View filing ↗
Earnings 10 Feb 2026

Reports full year 2025 financial results and corporate update

Shows how the company performed financially for the entire year, helping you understand if the business is growing.

SEC 8-K · filed 2026-02-10 View filing ↗

Common questions

How does Stocky track Exelixis, Inc.'s company events?

Stocky reads Exelixis, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was Exelixis, Inc.'s most recent SEC filing?

Exelixis, Inc.'s most recent tracked filing was a 10-Q on 5 Aug 2026: Reports Q2 2026 financial results and corporate update.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See Exelixis, Inc.'s full breakdown on Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.